Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Living-Donor Kidney Transplant Recipients
NCT07555106Phase 2Active, not recruiting
- Sponsor
- Universidad de Guadalajara
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in Kidney Transplant Failure (KTF), sponsored by Universidad de Guadalajara. Started Sep 2024; status: active, not recruiting.
02
Drugs
dapagliflozin
03
Conditions
Kidney Transplant Failure (KTF)
Beyond the preview
Go deeper on NCT07555106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07555106.